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Abstract 
Content: Strumpell-Lorrain disease - or familial spastic paraplegia (FSP) - is a rare hereditary 
neurological disorder, mainly characterized by variable degrees of stiffness and weakening of 
the muscles, with cognitive impairment, deafness, and ataxia in the more severe cases. We 
describe two female siblings with FSP programmed for cholecystectomy and subtotal colectomy, 
respectively, and also how we dealt with the anesthetic management in both cases and review 
the literature on this disease in relation to anesthesia.
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Introduction
Strumpell-Lorrain disease - also known as hereditary or fa-
milial spastic paraplegia (HSP or FSP) - comprises a group of 
rare neurological disorders affecting mainly the higher motor 
neurons, causing stiffness and weakness in the legs 1.
FSP is estimated to affect 7.4 in 100,000 individuals. It is 
a genetic, inherited or hereditary disease; that is, it is passed 
on from generation to generation. ‘Autosomal dominant’ (AD) 
FSP is the predominant form of the disorder, accounting for 
70-80% of all cases 1,2.
Hereditary spastic paraplegia is mainly characterized by 
variable degrees of stiffness and weakening of the muscles 
of the legs, muscle spasms, and bladder control problems. 
A limited number of affected families may present some of 
the following more serious alterations: mental retardation, 
dementia, epilepsy, peripheral neuropathy, retinopathy, 
deafness, ataxia, dysarthria, and disorders of the extrapy-
ramidal system 3.
The onset of the disease is usually gradual, slow and 
insidious, with symptoms that typically worsen progressively 
over time. The age at onset of the symptoms can be ex-
tremely variable among different families, as well as among 
affected members within the same family 1-3.
The diagnosis of hereditary spastic paraplegia is typically 
based on careful evaluation of the family and personal his-
tory of the patient, a complete physical examination, and 
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assessment of the characteristic symptoms and ﬁ ndings. 
Diagnostic evaluation can also include different specialized 
tests (neurophysiological or genetic studies) 4.
The treatment of hereditary spastic paraplegia involves 
medical control of the symptoms and physiotherapy. No 
treatment is presently able to slow or modify the course of 
the illness, though baclofen may help reduce spasticity in 
some patients 1,4.
Patients with neurological diseases pose a challenge when 
planning anesthesia. In such situations careful selection of 
the drug type and dose is required. Anesthesia is especially 
rare as in two patients with this disease in a very short space 
of time.
We describe two female siblings with FSP respectively 
programmed for cholecystectomy and subtotal colectomy – 
the two operations being spaced two months apart. The main 
interest of our study is that both patients were subjected to 
general anesthesia, with the use of a speciﬁ c reversal agent 
for non-depolarizing neuromuscular block.
Case Report 1 
The ﬁ rst case was a 47 year old woman diagnosed with FSP 
at 23 years of age, with hypertension and dependent upon 
others for her basic activities. Treatment was being provided 
with hydrochlorothiazide and baclofen. The preoperative 
laboratory tests (complete blood count, biochemistry and 
coagulation) and chest X-rays yielded no relevant ﬁ ndings. 
Upon arrival in the surgical area a venous catheter was in-
serted and 2 mg of intravenous midazolam was administered. 
In the operating room ECG, pulse oximetry, noninvasive blood 
pressure, bispectral index (BIS) and neuromuscular block 
(TOF and TOF ratio in the adductor muscle of thumb) were 
performed. After pre-oxygenating the patient, anesthetic 
induction was carried out with fentanyl 2 μg.kg-1, propofol 
1.5 mg.kg-1 and rocuronium 0.6 mg.kg-1; intratracheal intuba-
tion proved uneventful. Maintenance was carried out with 
sevoﬂ urane for a minimum alveolar concentration (MAC) of 
0.6 and remifentanil in continuous perfusion (0.1-0.2 μg.kg-1.
min-1), adjusting the dosage to achieve BIS values between 
35-50; relaxant use was not necessary during surgery. 
There were no hemodynamic or respiratory incidents 
during surgery. Before the end of the operation, intravenous 
dexketoprofen 50 mg, ondansetron 4 mg and acetaminophen 
1 g were administered. Extubation proved uneventful, fol-
lowing the administration of sugammadex (2 mg.kg-1 body 
weight) due to the presence of moderate neuromuscular 
block, until a TOF ratio of over 0.9 was obtained. The patient 
was discharged from the awakening unit to the hospital ward 
within three hours, without adverse events.
Case Report 2
The second case corresponded to the younger (43 years of 
age) female sibling of the above patient, who had been di-
agnosed with FSP at 16 years of age. In this case, the clinical 
course was more severe, with severe deafness, cognitive 
impairment, important vision deﬁ cit, neurogenic bladder, 
repeated episodes of sigmoid volvulus and dolichomegaco-
lon. Her usual treatment consisted of baclofen, tizanidine, 
clonazepam, and nicardipine. The patient was programmed 
for laparoscopic subtotal colectomy and ileostomy as treat-
ment for the recurrent volvulus episodes. The preoperative 
laboratory tests (complete blood count, biochemistry and 
coagulation) and chest X-rays showed no alterations other 
than mild anemia (hemoglobin 10 g.dL-1). 
Upon arrival in the surgical area, a venous catheter was 
inserted and 1.5 mg of intravenous midazolam was admin-
istered. Exploration revealed no clinical sign that predicted 
difﬁ cult intubation. In the operating room ECG, pulse oxi-
metry, noninvasive blood pressure, bispectral index (BIS) and 
neuromuscular block (TOF and TOF ratio in the adductor 
muscle of thumb) were performed. After pre-oxygenating the 
patient, anesthetic induction was carried out with fentanyl 
1.5 μg.kg-1, propofol 1.5 mg.kg-1 and rocuronium 0.6 mg.kg-1; 
intratracheal intubation proved uneventful. A central venous 
catheter was inserted through the right internal jugular 
vein, without incidents. Maintenance was carried out with 
a continuous infusion of propofol (4-8 mg.kg-1.h-1) until BIS 
values of 40-50 were obtained, and remifentanil in continu-
ous perfusion (0.1-0.2 μg.kg-1.min-1); relaxant use was not 
necessary during surgery. 
There were no hemodynamic or respiratory alterations 
during surgery, and no ventilatory problems were observed 
on performing the pneumoperitoneum at laparoscopy. Before 
the end of the operation, intravenous ondansetron 4 mg, 
paracetamol 1 g, dexketoprofen 50 mg and 150 μg fentanyl 
were administered. Following administration of a dose of 
2 mg.kg-1 of sugammadex, extubation proved uneventful, 
due to the presence of moderate neuromuscular block, to 
obtain a TOF ratio of over 0.9. The patient was moved to 
the resuscitation unit, where she remained for 48 hours 
with a favorable course. Serial laboratory tests and imaging 
studies were carried out and proved normal in all cases. The 
patient was discharged home after 8 days in the Department 
of Surgery.
Discussion
There are practically no studies in the literature on the safety 
of general anesthesia versus spinal anesthesia in Strumpell-
Lorrain disease. A PubMed literature search with the key-
words “Strumpell-Lorrain”, “hereditary spastic paraplegia” 
and “anesthesia” yielded a very limited number of articles, 
mainly in the ﬁ eld of obstetric anesthesia 5.
Three of the published articles used spinal anesthesia: 
McTiernan et al 5 described the use of epidural anesthesia for 
cesarean section, while Thomas et al. 6 and Deruddre et al. 7 
used intradural anesthesia likewise for cesarean section. In 
turn, Mclve et al. 8, Kunisawa et al. 9 and Dallman et al. 10 
decided to use general anesthesia for cesarean section, or-
thopedic surgery, and abdominal surgery, respectively.
The use of neuromuscular blockers is complicated in 
patients with familial spastic paraplegia. Succinylcholine 
is contraindicated since it may induce hyperkalemia, and 
there should be caution in the use of non-depolarizing muscle 
relaxants due to the risk of exaggerated muscle relaxation. 
The literature sources have not shown whether regional an-
esthesia exacerbate the neurological symptoms 11. However, 
regional anesthesia is not always possible. Therefore general 
anesthesia with non-depolarizing neuromuscular blockers 
would represent a safe alternative – particularly considering 
that there are have drugs offering rapid and safe reversal of 
muscle block induced by rocuronium and vecuronium. 
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In our two patients we chose general anesthesia because 
of the duration and complexity of both operations.
Great care is required at extubation in patients with FSP, 
particularly if neuromuscular blockers were administered 
during the operation. If possible, long-acting neuromuscu-
lar blockers should be avoided, with routine monitoring of 
neuromuscular relaxation throughout the operation, using 
a standard peripheral nerve stimulator 12. A TOF ratio of 
over 0.9 must be conﬁ rmed before awakening, accelerat-
ing patient recovery with neostigmine or drugs that selec-
tively bind aminosteroid neuromuscular blockers, such as 
sugammadex.
Although the anesthetic management differed between 
the two operations (Total Intravenous anesthesia versus inha-
latory anesthesia), agreement existed regarding the choice 
of muscle relaxant, i.e., rocuronium, due to the possibility 
of antagonizing its effects with sugammadex.
Functional deﬁ ciencies being similar to those prior to 
general anesthesia, subsequent follow-up of both patients 
revealed no signiﬁ cant worsening of neurological signs. 
Conclusion
The main interest of our study is that both patients were 
subjected to general anesthesia, with the use of a speciﬁ c 
reversal agent for non-depolarizing neuromuscular block, 
followed by complete recovery and no worsening of the 
existing neurological disease. 
This article is an original piece that has not been pre-
sented at any congress, and which has not received economi-
cal support. 
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